Affordable Access

deepdyve-link
Publisher Website

Genome-Directed Lead Discovery: Biosynthesis, Structure Elucidation, and Biological Evaluation of Two Families of Polyene Macrolactams against Trypanosoma brucei.

Authors
  • Cj, Schulze
  • Ms, Donia
  • Jl, Siqueira-Neto
  • D, Ray
  • Jevgenij Raskatov
  • Re, Green
  • Jh, Mckerrow
  • Ma, Fischbach
  • Rg, Linington
Type
Published Article
Journal
ACS Chemical Biology
Publisher
American Chemical Society
Volume
10
Issue
10
Pages
2373–2381
Identifiers
DOI: 10.1021/acschembio.5b00308
Source
UCSC Cancer biomedical-ucsc
License
Unknown

Abstract

Marine natural products are an important source of lead compounds against many pathogenic targets. Herein, we report the discovery of lobosamides A-C from a marine actinobacterium, Micromonospora sp., representing three new members of a small but growing family of bacterially produced polyene macrolactams. The lobosamides display growth inhibitory activity against the protozoan parasite Trypanosoma brucei (lobosamide A IC50 = 0.8 μM), the causative agent of human African trypanosomiasis (HAT). The biosynthetic gene cluster of the lobosamides was sequenced and suggests a conserved cluster organization among the 26-membered macrolactams. While determination of the relative and absolute configurations of many members of this family is lacking, the absolute configurations of the lobosamides were deduced using a combination of chemical modification, detailed spectroscopic analysis, and bioinformatics. We implemented a "molecules-to-genes-to-molecules" approach to determine the prevalence of similar clusters in other bacteria, which led to the discovery of two additional macrolactams, mirilactams A and B from Actinosynnema mirum. These additional analogs have allowed us to identify specific structure-activity relationships that contribute to the antitrypanosomal activity of this class. This approach illustrates the power of combining chemical analysis and genomics in the discovery and characterization of natural products as new lead compounds for neglected disease targets.

Report this publication

Statistics

Seen <100 times